Targeting Traumatic Brain Injury: Using Phage Display to Create a Specific Antibody for Neurocan Chondroitin Sulfate Proteoglycan Recognition

This project aims to address the current protocol regarding the diagnosis and treatment of traumatic brain injury (TBI) in medical industries around the world. Although there are various methods used to qualitatively determine if TBI has occurred to a patient, this study attempts to aid in the creation of a system for quantitative measurement of TBI and its relative magnitude.